We studied 25 patients who underwent percutaneous transluminal coronary angioplasty (PTCA) to determine the association of sympathovagal imbalance and the outcome of coronary angioplasty. We examined the profiles of heart rate variability (HRV) using echocardiography, stress thallium scanning and radionuclide angiography before, immediately after and 1 month after the procedure. Coronary angiography was followed up at 6 months or if restenosis was suspected, to determine whether restenosis had occurred. Frequency domain (LF/HF) and time domain (SDNN, SDANN-ind, and r-MSSD) parameters were analyzed. According to the evolution of each parameter, we classified the patients into Group Ax (improved in HRV profile) and Group Bx (deteriorated in HRV profile) [x=1 for LF/HF, 2 for SDNN, 3 for SDANNind, and 4 for r-MSSD]. We found that there was no definite association between Gensini score and HRV profiles at the baseline for each group. No significant changes existed between the HRV profiles before and immediately after PTCA. For the LF/HF ratio, 5 of 11 in Group B1 had restenosis while 0 of 14 in Group B2 and 1 of 19 in Group A2 had restenosis (p<0.01). There were no significant predictive values for SDANN-ind and r-MSSD (p=0.12 and 0.07, respectively). We conclude that the sympathovagal imbalance did not reflect the severity in coronary artery disease but was associated with restenosis after successful PTCA. (Jpn Heart J 1996; 37: 455-462) Key words: Heart rate variability Coronary artery disease Percutaneous transluminal coronary angioplasty (PTCA) Restenosis YMPATHOVAGAL imbalance has been reported after acute myocardial infarction (AMI)1-7) and chronic stable angina.8-10) Heart rate variability,
were analyzed at the Electrophysiology Laboratory of our institution using an analyzer around a microprocessor provided by Marquette Electronics (Orange County, USA). The two EGG analog channels, read by a Delmar Avionics electroscanner at 60 times the recording speed, were sampled at 10kHz. In addition to evaluation of the usual ECG variables, including identification of QRS widths and shapes and RR interval abnormalities, the sequences of all RR intervals were stored, and each RR interval was labeled with a code number identifying its normality or class of abnormality. The computer program automatically detects and labels each QRS complex and filters out the RR intervals that differ in duration by>30% from the previously accepted intervals. A physician would make a final check to detect the falsely labeled RR intervals and artifacts. Patients with persistent rhythm anomalies and tapes with excessive artifacts were excluded. The sequence of normal RR intervals (NN), after exclusion of each abnormal interval and of the two before and after it, used only for timekeeping purposes, was analyzed to compute frequency domain measures of heart rate variability.
The following time domain indices of heart rate variability were determined:
(1) r-MSSD=root-mean-square of successive differences in normal RR (NN) intervals among consecutive normal beats; (2) SDNN index=the mean of the standard deviations of all NN intervals for all 5-minute segments; (3) SDANN index=the standard deviations of the average NN intervals of all 5-minute segments. In the frequency domain, we determined: (1) total frequency power=the total power from 0.00066 to 0.40Hz expressed in milliseconds squared; (2) highfrequency power=the total power from 0.15 to 0.40Hz; (3) low-frequency power=the total power from 0.04 to 0.15Hz; (4) very-low frequency power=the total power from 0.0033 to 0.04Hz; (5) ultra-low frequency power=the total power from 0.00066 to 0.0033Hz. The power spectra were calculated (after correction for ectopy and noise by deletion and substitution of the subsequent NN interval) as the average of all nonoverlapping 2-minute power spectra using a 256-point fast Fourier transform with software provided by Marquette Electronics. Power spectral analysis of heart rate variability refers to the determination of the specific frequencies at which variations in heart rate occur. The technique yields a curve describing the amplitudes of the individual frequency components of a patient's heart rate variability. The amplitudes of the oscillation, or "power", which is amplitude squared, at any given frequency and the total contribution to heart rate variability contained within a range of frequencies can then be analyzed.
Because the distribution of the frequency domain measures of heart period variability are extremely skewed, the log transformation (Ln) of each measure (which produces nearly normal distribution) was applied before statistical analysis we classified the patients into group Ax and group Bx, in which group A had HRV parameters which improved while group B had HRV parameters which deteriorated; x=1 for LF/HF, 2 for SDNN , 3 for SDANN-ind and 4 for r-MSSD. Table I tabulates the comparisons between the two groups for various parameters. In addition to significant changes in each parameter between baseline and 1 month after PTCA, there were also significant differences between all of the group Ax and group Bx pairs . Relationship between heart rate variability and restenosis: Of the 25 patients, 5 (20%) developed restenosis in the subsequent 2-6 months . Comparing the HRV and the possibility of restenosis, we found that the difference in the frequencies between the groups with restenosis and without restenosis were significant in LF/HF and SDNN but not significant in SDANN-ind and r -MSSD (Table II) . This indicates that the HRV profiles at 1 month after PTCA have a predictive value for a subsequent restenosis.
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DISCUSSION
Our data have shown that the HRV profile had a poor correlation with the Gensini score in CAD patients needing PTCA, indicating that sympathovagal imbalance did not reflect the severity of the CAD score. The HRV showed a significant change 1 month after PTCA, indicating that sympathovagal influence could play some role in the recovery of mycardial ischemia after PTCA. This is consistent with the findings of our previous study.12) According to the literature, high frequency power represents a measure of the modulation of vagal tone by respiratory frequency and depth.18,19) Thus, the increase in high frequency power after coronary angioplasty reflects the recovery of parasympathetic nervous activity. Lower frequency power, measured under strictly controlled circumstances using autoregressive analysis, has been considered an indicator of sympathetic nervous system activity.2,20) However, during 24-hour recording it reflects predominantly parasympathetic activity.19,21,22) Therefore, the increase in low frequency power we observed after coronary angioplasty also indicates a recovery of parasympathetic activity.9) Most likely, regional left ventricular dysfunction may increase afferent sympathetic activity from the heart, which in turn inhibits efferent vagal nerve activity (other than inducing an increase in efferent sympathetic activity.) Thus, after coronary angioplasty the improvement in regional left ventricular dysfunction could have reduced afferent sympathetic activity, which results in an improvement in Holter measures of vagal activity. The existence in the left ventricle of receptors subserved by vagal afferent fibers must also be considered; the activation of these receptors elicits cardioinhibitory vasodepressor and sympathoinhibitory responses.23) In particular, the discharge pattern of ventricular receptors with unmyelinated afferents is influenced by increases in preload and afterload and by a change in cardiac contractility.24) Therefore, the recovery of regional left ventricular function may conceivably increase the firing of these vagal afferent fibers and, as a consequence, increase the activity of vagal fibers directed to the sinus node.9) In addition, evolution of the SDANN index which evaluates long-term RR variations can furthermore support the hypothesis that the improvement in heart rate variability after successful coronary angioplasty depends mainly upon the modification of para-sympathetic activity instead of sympathetic tone.12)
Our data furthermore show that HRV profiles at 1 month after PTCA play some part in predicting the possibility of restenosis occurring later on (Table II) . The underlying mechanism was uncertain. It probably means that hemodynamic changes and regional wall motion abnormalities due to myocardial ischemia may precede restenosis. In conclusion, the sympathovagal imbalance from the HRV profile in these paients did not reflect the severity of CAD but was associated with the restenosis after PTCA. Whether sympathovagal imbalance indicated by the HRV data causes abnormal vascular responses and possibly an atherosclerotic effect need further investigation.
